Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -12.66 | 35.37 |
| PEG Ratio (TTM) | -0.13 | 2.14 |
| P/S Ratio (TTM) | 0.23 | 3.97 |
| P/B Ratio (TTM) | 0.47 | 7.11 |
| P/FCF Ratio (TTM) | 4.78 | 22.53 |
| Price to 5YR AVG Earnings Ratio | 8.09 | 36.05 |
| Price to 5YR AVG FCF Ratio | 309.22 | 27.60 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.12% | 6.24% |
| ROE (TTM) | -3.67% | 21.24% |
| Net Profit Margin (TTM) | -1.63% | 10.56% |
| ROIC 5YR AVG | 7.11% | 19.22% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -46.31% | 77.39% | -215.42% |
| Revenue | -1.37% | 33.09% | 18.63% |
| Net Income | -45.48% | 95.74% | -223.73% |
| Cash Flow | 119.21% | 485.78% | 330.50% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.96 | 1.71 |
| Quick Ratio (TTM) | 1.96 | 1.71 |
| D/E Ratio (TTM) | 0.37 | 1.09 |
| Interest Coverage (TTM) | N/A | 29.53 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 3.55 | 5.27 |
| LTL to 5YR AVG FCF | 15.55 | 3.77 |
| Shares Outstanding Growth 5YR AVG | 12.88% | 2.53% |